These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15533809)

  • 1. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative biological effectiveness of 241Am relative to 192Ir for continuous low-dose-rate irradiation of BA1112 rat sarcomas.
    Morton J; Yabuki H; Porter EA; Rockwell S; Nath R
    Radiat Res; 1989 Sep; 119(3):478-88. PubMed ID: 2772139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
    Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
    Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of a brachytherapy model using 125I in a murine tumor system.
    Jones EL; Lyons BE; Douple EB; Filimonov A; Dain BJ
    Radiat Res; 1989 Apr; 118(1):112-30. PubMed ID: 2704784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of continuous low-dose-rate brachytherapy on the rectum of the rat.
    Armour EP; White JR; DeWitt CC; Corry PM; Martinez A
    Radiat Res; 1996 Apr; 145(4):474-80. PubMed ID: 8600508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
    Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
    Gutin PH; Bernstein M; Sano Y; Deen DF
    Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co.
    Reed JL; Rasmussen BE; Davis SD; Micka JA; Culberson WS; DeWerd LA
    Med Phys; 2014 Dec; 41(12):122103. PubMed ID: 25471976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative biological effectiveness of I-125 and Pd-103.
    Ling CC; Li WX; Anderson LL
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):373-8. PubMed ID: 7751179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The initial results on the radiobiological comparability of continuous LDR irradiation and PDR irradiation using a guinea pig skin animal model].
    Brock A; Prager W; Pohlmann S; Friedrich K
    Strahlenther Onkol; 1995 Nov; 171(11):641-5. PubMed ID: 7502227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
    Zilio VO; Joneja OP; Popowski Y; Chawla R
    Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
    Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF
    Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose rate effect of 125I irradiation on normal rabbit eyes and experimental choroidal melanoma.
    Yang CM; Olsen KR; Schwade JG; Houdek PV; Markoe AM; Pisciotta V; Wu X
    Exp Eye Res; 1993 Nov; 57(5):577-85. PubMed ID: 8282044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cure studies on the rat sarcoma BA1112 using continuous low-dose-rate radiation.
    Peschel RE; Martin DF; Fischer JJ
    Radiology; 1984 Sep; 152(3):801-3. PubMed ID: 6463263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy.
    Thomson RM; Furutani KM; Pulido JS; Stafford SL; Rogers DW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1261-9. PubMed ID: 20472360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.